Stay Ahead of the Game With Cencora (COR) Q1 Earnings: Wall Street's Insights on Key MetricsZacks Investment Research • 02/03/25
Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their PatientsBusiness Wire • 01/27/25
The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOCZacks Investment Research • 01/23/25
Bet on 5 Stocks With High ROE as Markets Surge on Cooling InflationZacks Investment Research • 01/16/25
Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating GrowthSeeking Alpha • 01/13/25
Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings ReleaseBusiness Wire • 01/08/25
Cencora Stock May Gain Following the Strategic Acquisition of RCAZacks Investment Research • 01/03/25
Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System CustomersBusiness Wire • 12/06/24
Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035Business Wire • 12/03/24